2020
Abstract PD9-05: Lack of background parenchymal enhancement suppression in breast MRI during neoadjuvant chemotherapy may be associated with inferior treatment response in hormone receptor positive breast cancer
Onishi N, Li W, Newitt D, Harnish R, Gibbs J, Jones E, Nguyen A, Wilmes L, Joe B, Campbell M, Basu A, van’t Veer L, DiMichele A, Yee D, Berry D, Albain K, Boughey J, Chien A, Clark A, Edmiston K, Elias A, Ellis E, Euhus D, Han H, Isaacs C, Khan Q, Lang J, Lu J, Meisel J, Mitri Z, Nanda R, Northfelt D, Sanft T, Stringer-Reasor E, Viscusi R, Wallace A, Yung R, Melisko M, Perlmutter J, Rugo H, Schwab R, Symmans W, Asare S, Yau J, Yau C, Esserman L, Hylton N. Abstract PD9-05: Lack of background parenchymal enhancement suppression in breast MRI during neoadjuvant chemotherapy may be associated with inferior treatment response in hormone receptor positive breast cancer. Cancer Research 2020, 80: pd9-05-pd9-05. DOI: 10.1158/1538-7445.sabcs19-pd9-05.Peer-Reviewed Original ResearchPathological complete responseBackground parenchymal enhancementInferior treatment responseHormone receptor-positive breast cancerPathologic complete response rateReceptor-positive breast cancerPositive breast cancerTreatment responseHR cohortBreast cancerBreast MRINeoadjuvant chemotherapyNon-pCRDegree of BPEI-SPY 2 TRIALQuantitative background parenchymal enhancementStage II/III breast cancerContralateral breast parenchymaPost-NAC MRIHormone receptor statusHR+ breast cancerEffects of chemotherapyEnhanced suppressionStatistically significant associationHR+ cancers
2003
Salivary Cortisol Responses to Dexamethasone in Adolescents With Posttraumatic Stress Disorder
LIPSCHITZ DS, RASMUSSON AM, YEHUDA R, WANG S, ANYAN W, GUEOGUIEVA R, GRILO CM, FEHON DC, SOUTHWICK SM. Salivary Cortisol Responses to Dexamethasone in Adolescents With Posttraumatic Stress Disorder. Journal Of The American Academy Of Child & Adolescent Psychiatry 2003, 42: 1310-1317. PMID: 14566168, DOI: 10.1097/01.chi.0000084832.67701.0d.Peer-Reviewed Original ResearchConceptsLow-dose dexamethasonePosttraumatic stress disorderSalivary cortisolStress disorderCo-occurring major depressionCurrent posttraumatic stress disorderAdrenal (HPA) axis abnormalitiesBaseline saliva samplesSalivary cortisol responseSalivary cortisol levelsEnhanced suppressionAxis abnormalitiesAdrenal axisPresent studyMajor depressionDexamethasone levelsTrauma controlsPTSD subjectsCortisol responseDay 1Cortisol levelsDexamethasoneCortisolSaliva samplesNontraumatized controls
1993
Enhanced suppression of cortisol following dexamethasone administration in posttraumatic stress disorder
Yehuda R, Southwick SM, Krystal JH, Bremner D, Charney DS, Mason JW. Enhanced suppression of cortisol following dexamethasone administration in posttraumatic stress disorder. American Journal Of Psychiatry 1993, 150: 83-86. PMID: 8417586, DOI: 10.1176/ajp.150.1.83.Peer-Reviewed Original ResearchConceptsPosttraumatic stress disorderDexamethasone administrationDexamethasone levelsLow-dose dexamethasone suppression testEnhanced negative feedback sensitivityStress disorderBaseline blood samplesDexamethasone suppression testNegative feedback sensitivityMale patientsHPA abnormalitiesSuppression testMajor depressionBlood samplesLow doseDiagnostic criteriaNormal subjectsPTSD patientsPatientsDexamethasoneCortisolGreater suppressionFeedback sensitivityEnhanced suppressionAdministration
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply